New injection targets chronic back pain in early trial
NCT ID NCT07520240
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This early-stage trial tests a single injection of ITX24-01 in 32 adults with severe chronic facet joint pain in the neck or lower back. The main goal is to see if the drug is safe and tolerable compared to a placebo. Researchers will also look for early signs of pain relief.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ITX24-01
- What this could lead to
- If it works, this could point toward a new treatment for severe chronic neck and lower back pain caused by facet joints.
- What could go wrong
- This is a very early Phase 1b trial with only 32 participants, so it is primarily checking safety, not effectiveness. The treatment may not reduce pain or could cause side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FACET JOINT PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sydney Pain Management Centre
Wahroonga, New South Wales, 2076, Australia
More trials for these conditions
Other studies related to the condition(s) this trial covers.